Delivery Order SPE2DB22D2206-SPE2DB23FHC62
- Not listed
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $1,731.28. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,009.08 and is a Firm Fixed Price Delivery Order with a period of performance through May 2, 2024. The contract is not designated as a set-aside....
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $14,500.81, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 28, 2024 and is a Delivery Order with a Firm Fixed Price pricing type. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,228.38 firm-fixed-price contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 22, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,672.66 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 18, 2023, with a completion date of September 19, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,777.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 4, 2025. The contract is not designated with a set-aside requirement, indicating open...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $10,973.57, is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,072.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Firm Fixed Price Delivery Order with a period of performance through June 6, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies, with a ceiling value of $12,158.86. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FHC62Delivery Order
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. The contract, valued at $3,405.72, is a Delivery Order with a Firm Fixed Price pricing type. It has an Ultimate Completion Date of May 11, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical covering a comprehensive range of pharmaceutical products and medical supplies. This IDC serves as the primary vehicle for Amerisourcebergen to deliver essential healthcare commodities to support military and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/10/23 |